Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Codexis Inc. diskutieren

Codexis Inc.

WKN: A0Q2S4 / Symbol: CDXS / Name: Codexis / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

2,48 €
-3,43 %

Buy Codexis Inc.

Einschätzung Buy
Rendite (%) 17,80 %
Kursziel
Veränderung
Endet am 07.12.19

Buy beendet

Einschätzung Buy
Rendite (%) -26,52 %
Kursziel 5,40
Veränderung
Endet am 21.07.24

Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $6.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat

Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat

Einschätzung Buy
Rendite (%) 49,88 %
Kursziel 8,35
Veränderung
Endet am 01.09.24

Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $9.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat

Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat

Einschätzung Buy
Rendite (%) 52,33 %
Kursziel 9,31
Veränderung
Endet am 06.11.24

Codexis, Inc. (NASDAQ: CDXS) had its price target lowered by analysts at Piper Sandler from $14.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for CDXS provided by MarketBeat

Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating.
Ratings data for CDXS provided by MarketBeat